S012 Nail Symposium
DESCRIPTION
This session provides the most comprehensive up-to-date information on diagnosis and treatment of major nail disorders. Recognized experts from around the world will discuss the most current scientific evidence regarding onychomycosis, nail unit psoriasis, nail unit lichen planus, nail unit squamous cell carcinoma, nail unit melanoma, nail disorders in skin of color patients, self-induced nail disorders, onychoscopy, as well as others.
LEARNING OBJECTIVES
Describe the most up to date therapy for patients with nail psoriasis.
Manage patients with onychomycosis and terbinafine resistance.
Describe the most up to date information on the treatment of nail unit melanoma.
SCHEDULE
9:00 AM
State of the Art Management of Onychomycosis in an Age of Resistance
Boni E. Elewski, MD, FAAD
9:10 AM
Selecting a Treatment Regimen for Nail Psoriasis Using the Most Up-to-Date Data
Shari Lipner, MD, PhD, FAAD
9:20 AM
Breakthroughs in Treatment for Nail Unit Lichen Planus
Molly A. Hinshaw, MD, FAAD
9:30 AM
Best Practices for Management of Periungual Warts
Nilton Gioia Di Chiacchio, MD, PhD
9:40 AM
Surgical and Non-Surgical Ingrown Nail Therapies
Judith Dominguez-Cherit, MD
9:50 AM
Questions and Answers
Judith Dominguez-Cherit, MD, Boni E. Elewski, MD, FAAD, Nilton Gioia Di Chiacchio, MD, PhD, Molly A. Hinshaw, MD, FAAD, Shari Lipner, MD, PhD, FAAD
10:00 AM
Pediatric Melanonychia: When should a biopsy or excision be recommended?
Je-Ho Mun, MD, PhD
10:10 AM
Adult Melanonychia: When to Worry, and Ideal Sampling Techniques
Jorge Ocampo-Garza, MD, IFAAD
10:20 AM
State of the Art Management of Nail Unit Melanoma
Nathaniel J. Jellinek, MD, FAAD
10:30 AM
State of the Art Diagnoais and Treatment of Nail Unit Squamous Cell Carcinoma
Julia O'Brien Baltz, MD, FAAD
10:40 AM
Anticipating and Managing Nail Surgery Complications
Bertrand Richert, MD, PhD, IFAAD
10:50 AM
Questions and Answers
Julia O'Brien Baltz, MD, FAAD, Nathaniel J. Jellinek, MD, FAAD, Je-Ho Mun, MD, PhD, Jorge Ocampo-Garza, MD, IFAAD, Bertrand Richert, MD, PhD, IFAAD
11:00 AM
Incorporating Onychoscopy Into Your Dermatology Practice
Antonella Tosti, MD
11:10 AM
Integrating Nail Clippings Into Your Practice For Indications Beyond Onychomycosis Evaluation
Adam Rubin, MD, FAAD
11:20 AM
Update on Nail Disorders in Skin of Color
Brian William Morrison, MD, MSc, FAAD
11:30 AM
Update on contact allergy to nail cosmetics and nail care products
Alexandra Flamm, MD, FAAD
11:40 AM
Confocal Applications for Nail Infections
Jane Margaret Grant-Kels, MD, FAAD
11:50 AM
Questions and Answers
Adam Rubin, MD, FAAD, Alexandra Flamm, MD, FAAD, Jane Margaret Grant-Kels, MD, FAAD, Brian William Morrison, MD, MSc, FAAD, Antonella Tosti, MD
DIRECTOR
Adam Rubin, MD, FAAD
SPEAKERS
Julia O'Brien Baltz, MD, FAAD
Judith Dominguez-Cherit, MD
Boni E. Elewski, MD, FAAD
Alexandra Flamm, MD, FAAD
Nilton Gioia Di Chiacchio, MD, PhD
Jane Margaret Grant-Kels, MD, FAAD
Molly A. Hinshaw, MD, FAAD
University of Wisconsin School of Medicine and Public Health
Nathaniel J. Jellinek, MD, FAAD
Shari Lipner, MD, PhD, FAAD
Brian William Morrison, MD, MSc, FAAD
Je-Ho Mun, MD, PhD
Seoul National University College of Medicine, Seoul, Republic of Korea
Jorge Ocampo-Garza, MD, IFAAD
Bertrand Richert, MD, PhD, IFAAD
Antonella Tosti, MD
HANDOUTS
DISCLOSURES
Julia O'Brien Baltz, MD, FAAD
No financial relationships exist with ineligible companies.
Judith Dominguez-Cherit, MD
No financial relationships exist with ineligible companies.
Boni E. Elewski, MD, FAAD
AbbVie – Investigator(Grants/Research Funding); Amgen – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Boehringer Ingelheim – Consultant(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Investigator(Grants/Research Funding); Eli Lilly and Company – Investigator(Grants/Research Funding); Foundation for Research & Education of Dermatology – Advisory Board(Honoraria); Incyte Corporation – Investigator(Grants/Research Funding); Janssen Pharmaceuticals, Inc – Consultant (1099 relationship)(Honoraria); Janssen-Ortho Inc. – Investigator(Grants/Research Funding); Novartis Pharmaceuticals Corp. – Consultant(Honoraria), Investigator(Grants/Research Funding); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); UCB – Consultant(Honoraria), Investigator(Grants/Research Funding);
Alexandra Flamm, MD, FAAD
No financial relationships exist with ineligible companies.
Nilton Gioia Di Chiacchio, MD, PhD
No financial relationships exist with ineligible companies.
Jane Margaret Grant-Kels, MD, FAAD
No financial relationships exist with ineligible companies.
Molly A. Hinshaw, MD, FAAD
BiaCure Therapies Inc – Founder(Stock);
Nathaniel J. Jellinek, MD, FAAD
No financial relationships exist with ineligible companies.
Shari Lipner, MD, PhD, FAAD
BelleTorus Corporation – Investigator(Grants/Research Funding); Moberg Pharma North America LLC – Investigator(Grants/Research Funding);
Brian William Morrison, MD, MSc, FAAD
No financial relationships exist with ineligible companies.
Je-Ho Mun, MD, PhD
No financial relationships exist with ineligible companies.
Jorge Ocampo-Garza, MD, IFAAD
No financial relationships exist with ineligible companies.
Bertrand Richert, MD, PhD, IFAAD
No financial relationships exist with ineligible companies.
Adam Rubin, MD, FAAD
New York University Langone Medical Center – Employee – Lab does not sell products(Salary);
Antonella Tosti, MD
Almirall – Advisory Board(Fees); Amgen – Advisory Board(Honoraria); Bristol-Myers Squibb – Advisory Board(Fees); Concert Pharmaceuticals – Investigator(Salary); DS Laboratories – Consultant(Fees); Eli Lilly and Company – Consultant(Honoraria), Investigator(Salary); L'Oreal USA Inc. – Advisory Board(Honoraria); Myovant Sciences – Advisory Board(Fees); Ortho Dermatologics – Advisory Board(Fees); Pfizer Inc. – Advisory Board(Honoraria); Springer Science & Business Media – Other(Patent royalties or other compensation for Intellectual Property Rights); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Fees); Taylor & Francis – Other(Patent royalties or other compensation for Intellectual Property Rights); The WellBeauty Company, LLC – Consultant (1099 relationship)(Fees); Thirty Madison, Inc. – Consultant(Honoraria); VeraDermics Inc. – Advisory Board(Honoraria);